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This study determined the haemolytic, haemagglutinating and antibiotic susceptibility activities of 
Plesiomonas shigelloides isolated from stool samples of patients attending different health centers in 
the Venda region of South Africa. P.shigelloides was isolated and identified using the API 20E, API 
20NE systems. Antibiotic susceptibility profiles of the isolates were determined using the disc diffusion 
method and analyzed according to NCCLS standards. The hemolytic and hemagglutination activities of 
the isolates on human, sheep, pig and chicken red blood cells were determined using the plate and 
slide methods. A total of 89 (13%) P. shigelloide were isolated from 660 samples. The hemolytic 
activities of the isolates were variable with no heamolysis on sheep red cells. 33 (37%) of isolates were 
beta lactamase producers. There was a high level of resistance to the penicilllins with 100% resistance 
to Penicillin G, Amoxicillin and Ampicillin. This study has demonstrated multiple resistance to different 
antibiotics and production of beta lactamase. Most of the isolates showed evidence of pathogenicity as 
demonstrated by hemolytic and haemagglutinating activities. 
 






Plesiomonas shigelloides is gram-negative rod which is 
found in freshwater, freshwater fish, shellfish and diffe-
rent types of animals such as cattle, goats, swine, cats, 
dogs, monkeys, vultures, snakes, and toads. P. shigelloi-
des, though aquatic in origin, is extensively distributed in 
the environment and is reportedly an agent of gastro-
enteritis (Salerno et al., 2007). Several reports have 
implicated the organism as a cause of diarrhoeal disease 
in humans and animals (Farmer et al., 1992). Human 
infections due to this bacterium are mostly waterborne. 
The organism may be present in unsanitary water, which 
has been used as drinking water, recreational water, or 
water used to rinse foods that are consumed without 
cooking or heating. P. shigelloides infections occur in 




*Corresponding author. E-mail: c355251@yahoo.com. 
tamination of freshwater (rivers, streams and ponds). 
Outbreaks of gastroenteritis linked to consumption of 
oysters contaminated with P. shigelloides have given 
impetus to the public health significance of the organism 
(Miller and Koburger, 1985). P. shigelloides gastro-
enteritis is usually a mild self-limiting disease with fever, 
chills, abdominal pain, nausea, diarrhea, or vomiting; 
symptoms may begin 20 - 24 h after eating contaminated 
food or drinking contaminated water (Ueda et al., 1999). 
Diarrhea is usually watery, non-mucoid, and non-bloody 
and in severe cases may be greenish-yellow, foamy, and 
blood tinged. 
Extra- intestinal complications such as septicemia 
(Nolte et al., 1988) may occur in people who are immuno-
compromised or seriously ill with cancer, blood disorders, 
or hepatobiliary disease. Inspite of the clinical signifi-
cance of P. shigelloides, little is known about the genetic 
landscape, updated antibiograms, structure of the popu-





(Salerno et al., 2007). As a prelude to unraveling the 
genetic diversity, which will impact on epidemiological 
control, a study on the prevalence, virulence potential 
and antibiograms of the organism is critical in order to 
gauge the extent of the problem, ascertain pathogenic 
factors and antibiograms of isolates for clinico-
epidemiological relevance and for empiric management 
of infections requiring antibiotics.  
In this first communication, we report on possible 
considerations of pathogenicity and antibiogram profiles 
of isolates as a prelude to an account of the genetic 




MATERIALS AND METHODS 
 
Study site and patients  
 
The study was carried out in the Vhembe district, Limpopo Province 
of South Africa. Diarrheic stool samples were collected from 
patients with diarrhea attending different hospitals in the region 
including Donald Frazer (Vhufuli), Elim, Tshilidzini, Siloam and 
Makhado hospitals. Each patient was given a 50 ml sterile plastic 
container and advised on how to collect the stool samples which 
were then kept in a cooler box with ice and taken to the Microbio-
logy laboratory, University of Venda for microbiological analysis. A 
total 660 stool samples were collected and demographic informa-





Specimens were investigated for the presence of P. shigelloides. 
The specimens were cultured using the method previously des-
cribed (Obi et al., 2007a, 2007b). Briefly, freshly collected stool 
specimens were plated onto MacConkey agar and xylose 
deoxycholate citrate agar (XDCA) and incubated at 37oC for 24 h, 
the suspected colonies for P. shigeloides were tested for cyto-
chrome oxidase (Kovac’s method) as previously reported (Wong et 
al., 2003). The oxidase positive strains were further evaluated by 
triple sugar iron agar slants and API-20E and API-20NE commercial 
strips (Analytab products, Inc., plainview, N.Y). In addition, the 
sugars listed in Table 1 were also used in conjunction with 
commercial kit to identify P. shielloides. 
 
 
Determination of beta-hemolytic activity  
 
Beta-hemolytic activity was determination, using sheep blood agar, 
human blood agar, pig blood agar and chicken blood agar. Single 
colonies of each isolates were streaked across the various blood 
agar plates using sterile inoculating wire loops. The inoculated 
blood agar plates were incubated at 37ºC for 18 to 24 h. After 
incubation the hemolytic activities were determined by observing 





The isolates were tested for the production of beta-lactamase. Two 
to three well-isolated colonies were picked and applied onto filter 
paper with applicator stick. A small quantity of Nitrocefin was drawn 
with a syringe and needle and a tiny drop of the fluid was applied 
onto each specimen (Samie et al., 2007). A change of colour of the 
filler paper from white to yellow indicated a positive reaction. 




Antibiotic susceptibility and screening for extended-spectrum 
-lactamases production  
 
Susceptibility tests were performed using the Kirby-Bauer disk 
diffusion method and following NCCLS guidelines. The antibiotic-
containing disks were obtained from oxoid and consisted of the 
following: Penicillin (PG, 10 units), Ciprofloxacin (CIP, 5 µg), 
Vancomycin (VA, 30 µg), Erythromycin (E, 30 µg), Tetracycline (T, 
30 µg), fusidic acid (FC, 30 µg), Cloxcillin (CL, 30 µg), Rifampicin 
(RF, 30 µg), Meropenem (MEM, 10 µg), Imepenem (IMI, 10 µg), 
chloramphenicol (C, 10 µg) amoxacillin/clavulanic acid (AMC, 30 
µg), nitrofurantoin (NI, 200 µg), Gentamycin (GN, 10 µg), Amikacin 
(AK, 10 µg), Ampicillin   (AMP, 10 µg), Cefoxitin (FOX, 30 µg), 
Nalidixic acid (NA, 30 µg), Piperacillin/Tazobactam (PTZ, 110 µg), 
Doxycycline (DOX, 30 µg), Novobiocin (NO, 30 µg), Cotrimoxazole 
( TS, 25 µg), Cefotaxime (CTX, 30 µg), Amoxycilin (AM, 30 µg), 
cephazolin (CZ ,30 µg),cefuroxime(CXM, 30 µg), Cefepime( CPM, 
30 µg) , and Cefotrizone (CRO, 30 µg). The MICs of cefotaxime, 
cefotaxime plus clavulanic acid, ceftazidime, ceftazidime plus 
clavulanic acid, cefepime, cefoxitin, nalidixic acid, ciprofloxacin, 
trimethoprim-sulfamethoxazole, imipenem, and meropenem were 
determined by E-test. The strips were used according to the 
manufacturer’s instructions (AB Biodisk, Solna, Sweden). Antibio-
grams were ascertained as already described (Samie et al., 2007; 
Obi et al., 2007). After incubation the organisms were classified as 
sensitive (S), and resistant (R) (NCCLS, 2003). A total of 28 
antibiotics were tested.  
 
 
Determination of minimum inhibitory concentrations by 
microdilution 
 
The minimum inhibitory concentrations (MICs) patterns of the 
isolates to 11 antibiotics were determined in microplates (NCCLS, 
2003). The antibiotics tested were AMX (amoxicillin) 8; AMC 
(amoxicillin/clavulanic acid) 4; CTX (cefotaxime) 8; CTC 
(cefotaxime/clavulanic acid) 4; CRX (ceftriaxone) 8; CRC 
(ceftriaxone/clavulanic acid) 4; CXM (cefuroxime) 8; CXC 
(cefuroxime/clavulanic acid) 4; CAZ (ceftazidime) 8; CAC 
(ceftazidime/clavulanic acid) 4; PIP (piperacillin) 16; PIT 
(piperacillin/tazobactam) 8; and FOX (cefoxitin) 8.  
 
 
Reference strains  
 
Escherichia coli ATCC 25922 and klebscella pneumoniae ATCC 




RESULTS AND DISCUSSION 
 
Out of a total of 660 samples collected from 580 (88%) 
females and 80 (12%) males with ages ranging from 1 -
60 years, only 89 (13%) were positive for P.shigelloides. 
Of 89 isolates of P. shigelloides isolated, 82 (92%) 
showed beta-haemolytsic activities on human red blood 
cells with 56 (63%) on chicken red blood cells whereas 
none (O%) showed haemolysis on sheep red blood cells 
and pig red blood cells. Only 33(37%) were beta-
lactamase producers. Tables 2 and 3 show the MICs of 
selected antibiotics. The MICs were measured in µg/ml 
as well as antibiotic resistance of P. shigelloides to 
different antibiotics.  
P. shigelloides is a bacterium of clinical significance but  











LDC ODC ADH Gas from 
glucose 
Acid from: 




TCBS       0% NACL 
+ + + - -                + + -                   + 
Oxidase ß-haemolysis from 
sheep blood 
Motility DNAse Indole Esculin Voges-Proskauer 
+ - + - + + - 
 
Abbreviations and symbols: LDC, lysine decarboxylase; ODC, ornithine decarboxylase, ADH arginine dihydrolase, TCBS, thiosulfate-citrate-bile 




Table 2. Minimum inhibitory concentrations (µg/ml) of selected antibiotics.  
 
P. shigelloides AMX CTX CTC CRX CXM CXC CAC PIT FOX 
P01 16 64 64 32 32 32 64 32 16 
P02 32 32 32 32 32 32 32 32 16 
P03 32 32 32 64 32 32 32 32 2 
P04 32 64 64 64 32 32 64 32 2 
P05 32 64 64 64 32 32 64 32 2 
P06 32 16 16 32 32 32 16 32 8 
P07 32 16 16 32 32 32 16 32 8 
P08 32 32 32 32 64 64 32 64 8 
P09 64 32 32 64 64 64 32 64 8 
P10 64 16 16 64 64 64 16 64 2 
P11 64 16 16 64 64 64 16 64 8 
P12 64 16 16 64 32 32 16 32 16 
P13 32 32 32 32 32 32 32 32 16 
P14 32 32 32 32 64 64 32 64 4 
P15 64 32 32 64 64 64 32 64 64 
P16 64 32 32 64 16 16 32 16 8 
P17 16 32 32 16 16 16 32 16 2 
P18 16 64 64 16 32 32 64 32 2 
P19 32 64 64 32 32 32 64 32 64 
P20 32 64 64 32 16 16 64 16 8 
P21 16 32 32 16 16 16 32 16 8 
P22 16 32 32 16 16 16 32 16 2 
P23 16 2 2 16 32 32 2 32 2 
P24 32 8 8 32 32 32 8 32 8 
P25 32 8 8 32 32 32 8 32 8 
P26 32 8 8 32 32 32 8 32 8 
P27 32 8 8 32 32 32 8 32 8 
P28 32 8 8 32 64 64 8 64 2 
P29 64 8 8 64 64 64 8 64 8 
P30 64 16 16 64 64 64 16 64 16 
P31 64 16 16 64 64 64 16 64 16 
P32 64 4 4 32 64 64 4 64 4 
P33 64 64 64 32 64 64 64 64 64 
P34 64 8 8 32 64 64 8 64 8 
P35 64 2 2 32 64 64 2 64 2 
P36 64 2 2 64 16 16 2 16 2 
P37 16 64 64 64 16 16 64 16 64 
P38 16 32 8 64 16 16 8 16 8 
P39 16 32 8 64 16 16 8 16 8 




 Table 2. Contd. 
 
P40 16 32 8 32 16 16 32 16 8 
P41 16 64 8 32 16 16 32 16 8 
P42 16 64 8 32 32 32 32 32 8 
P43 32 32 8 64 32 32 64 32 8 
P44 32 32 8 64 32 32 64 32 8 
P45 32 32 8 32 16 16 32 16 8 
 
CTX = cefotaxim , CXM = cefuroxime, CTC = cefotaxime/clavulanic acid, CRX = cefriazone, CXC = cefuroxime/clavulanic, 
CAC = cefazidime/clavulanic acid, PIT = piperacillin/tazobactam, FOX = cefoxitin. 
MIC is in µg/ml. 




Table 3. Antibiotic susceptibility of Plesiomonas shigelloides isolated from stool samples in the Venda region. 
 
Antibiotic Code Conc (µg) Total no. of  isolates No resistant (%) 
Penicillin G PG 10 89 89 (100%) 
Ciprofloxacin CIP 5 89 16 (17%) 
Vancomycin VA 30 89 89 (100%) 
Erythromycin E 15 89 63 (71%) 
Tetracycline T 30 89 42 (47%) 
Fusidic acid FC 10 89 89 (100%) 
Cloxacillin CX 5 89 89 (100%) 
Rifampicin RP 5 89 89 (100%) 
Meropenem MEM 10 89 18 (20%) 
Chloramphenicol C 30 89 65 (73%) 
Augmentin AUG 30 89 69 (76%) 
Nitrofurantoin NI 300 89 89 (100%) 
Gentamicin GM 10 89 33 (23%) 
Amikacin AK 30 89 20 (22%) 
Imipenem IMI 10 89 16 (17%) 
Ampicillin  AP 10 89 89 (100%) 
Ceftriaxone CRO 30 89 35 (39%) 
Nalidixic acid NA 30 89 47 (53%) 
Pipevacillin+ TazoBactam PTZ 110 89 22 (24%) 
Doxycycline DXT 30 89 28 (31%) 
Novobiocin NO 5 89 89 (100%) 
Cotrimoxazole TS 20 89 33 (23%) 
Cefotaxime CTX 30 89 42 (47%) 
Cefuroxime CXM 30 89 89 (63%) 
Cefepime CPM 30 89 18 (20%) 
Cephazoline CZ 30 89 16 (17%) 
Cefoxitin FOX 30 89 20 (22%) 




limited information is available on its antimicrobial sus-
ceptibility profiles and pathogenic factors in South Africa. 
The organism is implicated as a cause of sporadic and 
epidemic diarrhea in immunocompetent hosts and severe 
extraintestinal disease in immunocompromised indivi-
duals. A clinical approach to the treatment of P. 
shigelloides infections is based on the use of empiric 
antibiotic therapy especially in developing or rural com-
munities without adequate facilities for antimicrobial 
susceptibility testing.  
Antimicrobial susceptibility testing was performed on 89 
stool isolates of P. shigelloides isolated from patients with 
diarrhea in the Venda region of South Africa using a 
standard agar dilution technique. Results obtained show-
ed that imipenem, meropenem, cephazoline, cefepime, 
ciprofloxacin, gentamicin and cefoxitin  may  be  useful  in  




the treatment of P. shigelloides infections. A study by Obi 
et al. (2007) demonstrated that the carbapenems and 
cephalosporins had the best in vitro activity against 
Aeromonas species, an organism related to P. 
shigelloides. 
Results of our study are also in harmony with those of 
other researchers in terms of susceptibility of the orga-
nism to ciprofloxacin, gentamicin and imipenem (Kain 
and Kelly, 1989; Stock and Wiedemann, 2001; Wong et 
al., 2003). However, the organism showed resistance to 
multiple antibiotics such as penicillin, vancomycin amoxi-
cillin, tetracycline and erythromycin. 
Results also showed that majority of the isolates (92%) 
were beta-hemolytic and 63% showed haemolysis on 
human red blood cells. 37% of the isolates were beta-
lactamase producers. Haemolysis and beta-lactamase 
production are indices of pathogenicity and results on 
these pathogenic factors simulate previous findings on 
related organisms (Obi et al., 2007; Samie et al; 2007; 
Wong et al., 2003).  
In conclusion, meropenem and imipenem had good 
activity against P. shigelloides isolated from stool sam-
ples and may be useful in cases of gastrointestinal 
infection caused by P. shigelloides. However, further 
studies are needed to unravel genetic profiles of resis-
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